Pipex Pharmaceuticals, Inc. ("Pipex") AMEX:PP is a development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and autoimmune diseases.
Stock information
Pipex is traded on the AMEX (ticker symbol PP).
In the news
ANN ARBOR, Mich., Oct. 16, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (the "Company" or "Pipex") (AMEX:PP), a pharmaceutical company developing innovative late-stage oral drug candidates for the treatment of autoimmune and central nervous system diseases, announced today that it has completed a corporate name change from Pipex Pharmaceuticals, Inc. to Adeona Pharmaceuticals, Inc.
- Pipex cuts jobs after drug application delay, Ann Arbor News, March 2008
Pipex is developing late-stage drug candidates like oral TTM, formerly known as Coprexa, to treat neurological and autoimmune diseases like Wilson's disease. The initial application for oral TTM was rejected in January.
